Trade facing article
Written for clinic owners and staff. The patient facing material is in checks before you agree. This publication names no clinics, practitioners or brands, and does not rank businesses it has not assessed.
Most discussions of patient safety in aesthetics are about technique. The more consequential ones are about process, and process in a private clinic is largely determined by commercial decisions made outside the treatment room. This article maps the points where a growth tactic becomes a clinical exposure.
Same day treatment
Booking assessment and treatment in one appointment increases conversion. It also removes the interval that professional guidance expects a patient to have in order to reach a voluntary decision, and it removes the practitioner's own opportunity to reflect.
Where a claim later turns on consent, the timeline is the first thing examined. A record showing that information was given and treatment performed within the hour is a weak defence, whatever the form says. This is not a hypothetical: since Montgomery, consent claims turn on whether the patient could meaningfully weigh the risks, and a same day process makes that harder to demonstrate.
Time limited offers and inducements
Professional guidance for doctors offering cosmetic interventions warns specifically against inducements and time limited offers that could encourage people to make ill considered decisions. Consumer protection law separately bans falsely claiming very limited availability in order to force an immediate decision.
A promotion is therefore not only a marketing decision. Where a registered clinician is associated with the business, it is a professional standards question about them personally.
What patients are entitled to from your process
- A consent discussion with the person who will perform the procedure.
- Time between the discussion and the procedure, free of expiring offers.
- Assessment by the prescriber before a prescription only medicine is prescribed for them.
- A written statement of what a correction or complication would cost.
- A named out of hours contact who is a clinician.
Every item here is also something almost no competitor can currently put on a website truthfully.
Package pre payment
Selling a course up front improves cash flow and retention. It also means that a patient who is unhappy after the first session has a financial reason to continue, which is the opposite of what you want clinically. A patient who proceeds because they have already paid has not made a fresh decision, and the consent record for session four is the record for a decision made before session one.
A workable middle position is to sell packages with a stated, written policy for exiting after any session, and to document a short reconsent at each visit. Both are cheap, and both are strong evidence later.
Non clinical consultations
Using non clinical staff to conduct consultations increases throughput. It also moves the consent discussion away from the person performing the procedure, contrary to explicit guidance, and it moves the assessment away from the prescriber where a prescription only medicine is involved.
Where a prescriber is prescribing for patients they have not personally assessed, that is a prescribing standards issue for them, and it is one that regulators have acted on. No commercial arrangement transfers it away from them.
A patient journey designed so that the first meeting with the treating clinician takes place after payment. Once money has changed hands, a decision to decline treatment becomes a refund conversation, and clinicians decline less often when it does.
Vulnerability, and the duty to decline
Guidance expects clinicians to consider whether a patient may have body dysmorphic disorder or other psychological vulnerability, and to be prepared to decline. A business whose targets are volume based creates pressure in the opposite direction, and the pressure is felt by the individual clinician whose registration is at stake.
Two practical measures help. Record declines as a positive metric rather than a lost sale, and remove any individual incentive that makes declining costly to the person making the decision.
Complications infrastructure
The questions this publication tells patients to ask are, from the clinic's side, an infrastructure list: hyaluronidase held on site with a lawful supply route, staff trained and insured for complication management, a documented protocol, out of hours contact that reaches a clinician, and a written correction and refund policy.
None of that generates revenue. All of it determines what happens on the worst day, and a clinic that has it can say so in its marketing, which very few competitors can.
Records, which decide everything afterwards
Product name and batch number recorded for every treatment. Consultation notes recording what was specifically discussed with this patient, including the risks flagged as significant to them. Prescriber name and assessment recorded. Photographs standardised. Consent dated separately from treatment.
These are unglamorous, and they are what a regulator, an insurer and a court will look at. A clinic with complete records and a poor outcome is in a materially better position than a clinic with an excellent outcome and thin records, because the second one cannot demonstrate anything.
The alignment worth noticing
Almost every measure above is also a marketing asset in a category where patients are increasingly wary. Named and registered practitioners, prescriber present, complications policy published, correction costs stated, standardised photography, no expiring discounts. That is a compliance list and a differentiation list at the same time, and the clinics that treat it as the second thing tend to be the ones that never have to argue about the first.